Short stem total hip arthroplasty with the direct anterior approach demonstrates suboptimal fixation.
Guido Garavaglia, Amanda Gonzalez, Christophe Barea...
https://pubmed.ncbi.nlm.nih.gov/33427897/Actively Recruiting
Led by Istituto Ortopedico Rizzoli · Updated on 2026-05-20
400
Participants Needed
1
Research Sites
169 weeks
Total Duration
Researchers are evaluating the clinical, radiographic, and perioperative outcomes of short femoral stems used during primary total hip replacement performed through a minimally invasive direct anterior approach. These short femoral stems aim to preserve bone, provide more natural load transfer, and allow easier implantation, especially in younger and active patients. The study addresses conflicting past results regarding implant longevity and radiographic changes and seeks to provide comprehensive evidence on the performance of these implants over time. The study involves patients undergoing total hip arthroplasty using a cementless hydroxyapatite-coated triple-tapered short femoral stem implanted through the direct anterior approach. The investigation is both retrospective and prospective, focusing on patients treated for hip arthritis or osteonecrosis. Outcomes will include perioperative complications, wound and tissue conditions, bleeding, postoperative pain, functional recovery, clinical scores, implant survivorship, and radiographic results at short- and mid-term follow-up. Participants will be assessed through scheduled clinical and radiographic exams, with adverse events continuously monitored. The main outcome is implant survival at least five years post-surgery, alongside perioperative complication rates on the surgery day. Secondary outcomes include radiological evaluations conducted at similar follow-up times. The study requires a minimum follow-up of two years and includes patients aged 18 and older who consent to participate.
CONDITIONS
Retrospective and Prospective Evaluation of Hip Short Stem Performed by Anterior Approach
S
Stefano Lucchini, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Istituto Ortopedico Rizzoli
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Day of the surgery
Participants undergo total hip arthroplasty via the direct anterior approach and receive immediate post-operative care.
1 surgery day visit
Duration - At least 5 years
Participants are monitored for implant survival and radiological outcomes for at least 5 years following surgery.
Periodic visits over 5 years for assessments
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Guido Garavaglia, Amanda Gonzalez, Christophe Barea...
https://pubmed.ncbi.nlm.nih.gov/33427897/Federico Giardina, Francesco Castagnini, Susanna Stea...
https://pubmed.ncbi.nlm.nih.gov/29395723/Istituto Ortopedico Rizzoli
Lead Sponsor